Author + information
- Received April 17, 2018
- Revision received September 5, 2018
- Accepted September 11, 2018
- Published online November 26, 2018.
- aDepartment of Medicine, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
- bDepartment of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee
- ↵∗Address for correspondence:
Dr. Joshua A. Beckman, Vanderbilt University, 1215 21st Avenue South, Nashville, Tennessee 37215.
Peripheral artery disease is a common yet underdiagnosed cause of morbidity worldwide. Significant recent advances in management have resulted in new guideline creation for the diagnosis and management of peripheral artery disease in the United States and Europe. Here, we analyze each set of guidelines with special attention to those areas where the 2 groups disagree. Both groups emphasize the importance of risk factor reduction, including smoking cessation, lipid lowering, blood pressure management, and glucose control. The U.S. guidelines place additional attention on lifestyle factors, including regular physical activity and supervised exercise. The European guidelines offer a number of recommendations for revascularization in patients with limb-threatening ischemia. Both agree that more evidence is needed to understand which patients are at highest risk for tissue loss. A consistent charge to each committee fostering a similar approach to available data and more randomized studies would align recommendations across both organizations.
Dr. Beckman has served as a consultant for AstraZeneca, Janssen, Antidote Pharmaceuticals, Sanofi, Bristol-Myers Squibb, and Merck; and has served on the data and safety monitoring board for Bayer and Novartis. Dr. Kithcart has reported that he has no relationships relevant to the contents of this paper to disclose.
- Received April 17, 2018.
- Revision received September 5, 2018.
- Accepted September 11, 2018.
- 2018 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.